Survival disparities in patients with lymphoma according to place of residence and treatment provider: A population-based study

Journal of Clinical Oncology

Volumn 27, Issue 32, 2009, Pages 5376-5382

  Loberiza Jr , Fausto R ^a   Cannon, Anthony J ^a   Weisenburger, Dennis D ^a   Vose, Julie M ^a   Moehr, Matt J ^a   Bast, Martin A ^a   Bierman, Philip J ^a   Bociek, R Gregory ^a   Armitage, James O ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER SURVIVAL; COMMUNITY BASED PROVIDER; COMPARATIVE STUDY; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HEALTH CARE PERSONNEL; HEALTH DISPARITY; HIGH RISK PATIENT; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; ONCOLOGY; OVERALL SURVIVAL; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; RISK FACTOR; RURAL AREA; UNITED STATES; UNIVERSITY BASED PROVIDER; URBAN AREA; CAUSE OF DEATH; GEOGRAPHY; HEALTH CARE SURVEY; LYMPHOMA; MIDDLE AGED; MORTALITY; RURAL POPULATION; STATISTICS; SURVIVAL; URBAN POPULATION;

ADULT; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; FEMALE; GEOGRAPHY; HEALTH CARE SURVEYS; HEALTH PERSONNEL; HUMANS; LYMPHOMA; MALE; MIDDLE AGED; NEBRASKA; RETROSPECTIVE STUDIES; RURAL POPULATION; SURVIVAL ANALYSIS; URBAN POPULATION; YOUNG ADULT;

EID: 73949095139     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2009.22.0038     Document Type: Article

References (49)

1. Bray P, Roupe M, Young S, et al: Feasibility and effectiveness of system redesign for diabetes care management in rural areas: The eastern North Carolina experience. Diabetes Educ 31:712-718, 2005
2. Johnson EA, Webb WL, McDowall JM, et al: A field-based approach to support improved diabetes care in rural states. Prev Chronic Dis 2:A08, 2005
3. Larson SL, Fleishman JA: Rural-urban differences in usual source of care and ambulatory service use: Analyses of national data using urban influence codes. Med Care 41:III65-III74, 2003
4. Lutfiyya MN, Lipsky MS, Wisdom-Behounek J, et al: Is rural residency a risk factor for overweight and obesity for U.S. children? Obesity (Silver Spring) 15:2348-2356, 2007
5. Onega T, Duell E, Shi X, et al: Geographic access to cancer care in the U.S. Cancer 112:909-918, 2008
6. Parikh-Patel A, Bates JH, Campleman S: Colorectal cancer stage at diagnosis by socioeconomic and urban/rural status in California 1988-2000. Cancer 107:1189-1195, 2006
7. Rao K, Darrington D, Schumacher J, et al: Disparity in survival outcome after hematopoietic stem cell transplantation for hematologic malignancies according to area of primary residence. Biol Blood Marrow Transplant 13:1508-1514, 2007
8. Siminerio L, Piatt G, Zigbor J: Implementing the chronic care model for improvements in diabetes care and education in a rural primary care practice. Diabetes Educator 31:225-234, 2005
9. Ayanian J, Guadagnoli E: Variation in breast cancer treatment by patient and provider characteristics. Breast Cancer Res Treat 40:65-74, 1996
10. Wiklund O, Haversen L, Pettersson C, et al: How can we prevent cardiovascular disease in diabetes? J Intern Med 262:199-207, 2007
11. Coughlin SS, Richards TB, Thompson T, et al: Rural/nonrural differences in colorectal cancer incidence in the United States, 1998-2001. Cancer 107:1181-1188, 2006
12. Mandelblatt JS, Yabroff KR, Kerner JF: Equitable access to cancer services: A review of barriers to quality care. Cancer 86:2378-2390, 1999
13. Higginbotham JC, Moulder J, Currier M: Rural v. urban aspects of cancer: First-year data from the Mississippi Central Cancer Registry. Fam Community Health 24:1-9, 2001
14. McCullough D, Price M, Hindmarsh M, et al: A population-based approach to diabetes management in a primary care setting: early results and lessons learned. Eff Clin Pract 1:12-22, 1998
15. Montori VM, Dinneen SF, Gorman CA, et al: The impact of planned care and a diabetes electronic management system on community-based diabetes care: The Mayo Health System Diabetes Translation Project. Diabetes Care 25:1952-1957, 2002
16. Wilcox B: How do you make a difference in patients' lives through your role as a nurse navigator? ONS Connect 22:12, 2007
17. Hillner BE, Smith TJ, Desch CE: Hospital and physician volume or specialization and outcomes in cancer treatment: Importance in quality of cancer care. J Clin Oncol 18:2327-2340, 2000
18. Hodgson DC, Fuchs CS, Ayanian JZ: Impact of patient and provider characteristics on the treatment and outcomes of colorectal cancer. J Natl Cancer Inst 93:501-515, 2001
19. Holm T, Johansson H, Cedermark B, et al: Influence of hospital- and surgeon-related factors on outcome after treatment of rectal cancer with or without preoperative radiotherapy. Br J Surg 84:657-663, 1997
20. Hart LG, Larson EH, Lishner DM: Rural definitions for health policy and research. Am J Public Health 95:1149-1155, 2005
21. Sinott R: Virtues of the Haversine. Sky and Telescope 68:159, 1984
22. Arora NK, Hamilton AS, Potosky AL, et al: Population-based survivorship research using cancer registries: A study on non-Hodgkin's lymphoma survivors. J Cancer Surviv 1:49-63, 2007
23. Bierman PJ, Sweetenham JW, Loberiza FR, et al: Syngeneic hematopoietic stem cell transplantation for non-Hodgkin's lymphoma: A comparison with allogeneic and autologous transplantation. J Clin Oncol 15:3744-3753, 2003
24. Navarro WH, Loberiza FR, Bajorunaite R, et al: Impact of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 12:541-551, 2006
25. Pulte D, Gondos A, Brenner H: Ongoing improvement in outcomes for patients diagnosed as having non-Hodgkin lymphoma from the 1990s to the early 21st century. Arch Intern Med 10:469-476, 2008
26. The International Non-Hodgkin's Lymphoma Prognostic Factors Project: A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 329:987-994, 1993
27. Kaplan E, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
28. Cox D: Regression models and life tables. J R Stat Soc Ser A 34:187-220, 1972
29. Klein J: Chapter 2: Discretizing a continuous covariate in survival studies in Balakrishnan N, Rao CR (eds): Handbook of Statistics. Amsterdam, the Netherlands, Elsevier Science, 2008, pp 27-42
30. Andre M, Henry-Amar M, Pico JL, et al: Comparison of high-dose therapy and autologous stemcell transplantation with conventional therapy for Hodgkin's disease induction failure: A case-control study: Societe Francaise de Greffe de Moelle. J Clin Oncol 17:222-229, 1999
31. Gianni AM, Bregni M, Siena S, et al: High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma. N Engl J Med 336:1290-1297, 1997
32. Gisselbrecht C, Lepage E, Molina T, et al: Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma. J Clin Oncol 20:2472-2479, 2002
33. Haioun C, Lepage E, Gisselbrecht C, et al: Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: Final analysis of the prospective LNH87-2 protocol: A Groupe d'Etude des Lymphomes de l'Adulte study. J Clin Oncol 18:3025-3030, 2000
34. Philip T, Armitage JO, Spitzer G, et al: High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma. N Engl J Med 316:1493-1498, 1987
35. Philip T, Guglielmi C, Hagenbeek A, et al: Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 333:1540-1545, 1995
36. Vose JM, Rizzo DJ, Tao-Wu J, et al: Autologous transplantation for diffuse aggressive non-Hodgkin lymphoma in first relapse or second remission. Biol Blood Marrow Transplant 10:116-127, 2004
37. Yuen AR, Rosenberg SA, Hoppe RT, et al: Comparison between conventional salvage therapy and high-dose therapy with autografting for recurrent or refractory Hodgkin's disease. Blood 89:814-822, 1997
38. Probst JC, Laditka SB, Wang JY, et al: Effects of residence and race on burden of travel for care: Cross sectional analysis of the 2001 US National Household Travel Survey. BMC Health Serv Res 7:40, 2007
39. Bass EB, Jenckes MW, Fink NE, et al: Use of focus groups to identify concerns about dialysis: Choice Study. Med Decis Making 19:287-295, 1999
40. Coiffier B, Herbrecht R, Tilly H: GELA study comparing CHOP and R-CHOP in elderly patients with DLBCL: 3-year median follow-up with an analyis according to co-morbidity factors. Proc Am Soc Clin Oncol 22:596, 2003 (abstr 2395)
41. Coiffier B, Lepage E, Briere J, et al: CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346:235-242, 2002
42. Habermann TM, Weller EA, Morrison VA, et al: Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma. J Clin Oncol 24:3121-3127, 2006
43. Krouse R, Grant M, Ferrell B, et al: Quality of life outcomes in 599 cancer and non-cancer patients with colostomies. J Surg Res 138:79-87, 2007
44. Moist LM, Bragg-Gresham JL, Pisoni RL, et al: Travel time to dialysis as a predictor of health-related quality of life, adherence, and mortality: The Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 51:641-650, 2008
45. Pandey M, Thomas BC, SreeRekha P, et al: Quality of life determinants in women with breast cancer undergoing treatment with curative intent. World J Surg Oncol 3:63, 2005
46. Vose JM, Link BK, Grossbard ML, et al: Phase II study of rituximab in combination with chop chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma. J Clin Oncol 19:389-397, 2001
47. Voutilainen P, Backman K, Isola A, et al: Family members' perceptions of the quality of long-term care. Clin Nurs Res 15:135-149, 2006
48. Adams EK, Houchens R, Wright GE, et al: Predicting hospital choice for rural Medicare beneficiaries: The role of severity of illness. Health Serv Res 26:583-612, 1991
49. Adams EK, Wright GE: Hospital choice of Medicare beneficiaries in a rural market: Why not the closest? J Rural Health 7:134-152, 1991